Skip to content

In-house Produced PMMA- Versus PEEK-cages

Clinical Characterization of In-house Produced PMMA-cages in Patients With Cervical Pathology

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01607775
Acronym
Palcage
Enrollment
88
Registered
2012-05-30
Start date
2009-02-28
Completion date
2012-02-29
Last updated
2012-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Disc Degeneration, Cervical Stenosis

Brief summary

Subsidence of cervical cages is a common problem. For the study, a new polyacrylmethacrylate cage was designed and prospectively implanted in patients with a mono- or bilevel cervical pathology. As control, a commercially available PEEK-cage was used, patients were randomized using minimization randomization, controlling for age and bone mineral densitiy. The investigators hypothesize that the newly developed cage has similar clinical and radiological qualities compared to the PEEK-cage, but at a much more favourable cost-performance ratio.

Interventions

DEVICEImplantation of a PEEK-cage

A commercially avaliable cuboid cervical cage will be implantet

DEVICEPMMA-cage

The in-house produced cervical cage will be implanted

Sponsors

Universitätsmedizin Mannheim
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* virgin spines * no emergency operation * age above 18 * sufficient knowledge of the German language * indication for anterior cervical discectomy and fusion * absence of concomitant spinal disease

Exclusion criteria

* prior cervical surgery * indications other than ACDF * concomitant neoplastic, metabolic, severe general or infectious disease

Design outcomes

Primary

MeasureTime frameDescription
Clinical outcome (NDI)12 months postoperativeNDI (Neck disability index) will be measured prior to surgery and 12 months after surgery. A difference of 20% between both groups is considered to be clinically significant, which is proposed for the experimental implant (PMMA-cage).

Secondary

MeasureTime frameDescription
Clinical outcome (VAS-neck), Subsidence12 months postoperative1. VAS-neck will be measured prior to surgery and 12 months after surgery. A difference of 20% between both groups is considered to be clinically significant, which is proposed for the experimental implant (PMMA-cage). 2. Cage Subsidence will be measured using lateral radiographs prior to surgery and 12 months after surgery. Due to an improved cage design, significantly less subsidence is proposed for the experimental implant (PMMA-cage).

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026